Eric Trestman, MD
Vascular Surgery · Humble, TXNPI 1639412018
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. It is spread thinly across 59 manufacturers, the largest accounting for just 20.6%. Among vascular surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 690 payments — averaging $287.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$41K
- Inari Medical, Inc.$39K
- Cook Incorporated$30K
- Bolton Medical Inc$28K
- Philips North America LLC$15K
- Angiodynamics, Inc.$14K
- plus $32K from 53 others
Across 103 payments — averaging $1252.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$109K
- Vesper Medical$20K
What the payments were for
- Consulting fees$55,56528%
- Speaking & faculty fees$76,72339%
- Travel & lodging$7,5204%
- Food & beverage$28,26114%
- Education$16,5008%
- Other$13,4867%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$44,474
- FLOWTRIEVER CATHETER, S$30,280
- EKOSONIC$18,000
- Zenith$14,170
- Auryon Laser System 100-120 Vac$13,486
- Zenith Spiral-Z$13,030
- Relay Grafts$11,886
- Grafts$10,696
- ZOOM 88-T LARGE DISTAL PLATFORM$8,550
- GENERAL - THERAPIES$8,225
- (9520) IGT Devices Undivided$5,460
- GENERAL VASCULAR INTERVENTION$5,344
- VENOUS WALLSTENT$4,950
- ENDURANT IIS$4,814
- TREO ABDOMINAL STENT-GRAFT SYSTEM$3,415
- Cook$3,009
- (R11) US EQ Undivided$2,503
- ENROUTE Transcarotid Neuroprotection System$2,275
- ENROUTE Transcarotid Stent$1,966
- (7881) Ultrasound Und$1,560
How this compares
$198,054 in reported general payments places this provider in the 95th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 82 | $60,148 |
| ClopidogrelClopidogrel Bisulfate | 170 | $1,317 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $86 |
| Prednisone | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $275 | $60,14882 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Humble
- Hunter RayHumble$150K
- Kousta FotehHumble$148K
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.